Comprehensive analysis of the prognostic value and immunological role of IDO1 gene in pan-cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Comprehensive analysis of the prognostic value and immunological role of IDO1 gene in pan-cancer ; volume:29 ; number:1 ; day:27 ; month:3 ; year:2024 ; pages:1-19 ; date:12.2024
European journal of medical research ; 29, Heft 1 (27.3.2024), 1-19, 12.2024
- Urheber
-
Lin, Kaili
Wang, Yongfeng
Liu, Fangyu
You, Taifu
Liu, Xiongxiong
Liu, Runzhang
Li, Zeyang
Zhen, Chunyu
Zhang, Yunxia
Liu, Xingguang
Cai, Hui
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40001-024-01766-y
- URN
-
urn:nbn:de:101:1-2406130844330.447676623668
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lin, Kaili
- Wang, Yongfeng
- Liu, Fangyu
- You, Taifu
- Liu, Xiongxiong
- Liu, Runzhang
- Li, Zeyang
- Zhen, Chunyu
- Zhang, Yunxia
- Liu, Xingguang
- Cai, Hui
- SpringerLink (Online service)
Ähnliche Objekte (12)
A comprehensive prognostic and immunological implications of PFKP in pan-cancer
Comprehensive pan-cancer analysis of STAT3 as a prognostic and immunological biomarker
Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker
Comprehensive pan-cancer analysis of ZNF337 as a potential diagnostic, immunological, and prognostic biomarker
Pan-cancer analysis of COL15A1: an immunological and prognostic biomarker
Pan-cancer analysis of the prognostic and immunological role of PAQR4
MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer
Prognostic value and immunological role of PD-L1 gene in pan-cancer
Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
PHF5A is a potential diagnostic, prognostic, and immunological biomarker in pan-cancer
PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer
A comprehensive prognostic and immunological implications of PFKP in pan-cancer
Comprehensive pan-cancer analysis of STAT3 as a prognostic and immunological biomarker
Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker
Comprehensive pan-cancer analysis of ZNF337 as a potential diagnostic, immunological, and prognostic biomarker
Pan-cancer analysis of COL15A1: an immunological and prognostic biomarker
Pan-cancer analysis of the prognostic and immunological role of PAQR4
MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer
Prognostic value and immunological role of PD-L1 gene in pan-cancer
Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
PHF5A is a potential diagnostic, prognostic, and immunological biomarker in pan-cancer
PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer
A comprehensive prognostic and immunological implications of PFKP in pan-cancer
Comprehensive pan-cancer analysis of STAT3 as a prognostic and immunological biomarker
Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker
Comprehensive pan-cancer analysis of ZNF337 as a potential diagnostic, immunological, and prognostic biomarker
Pan-cancer analysis of COL15A1: an immunological and prognostic biomarker
Pan-cancer analysis of the prognostic and immunological role of PAQR4
MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer
Prognostic value and immunological role of PD-L1 gene in pan-cancer
Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
PHF5A is a potential diagnostic, prognostic, and immunological biomarker in pan-cancer